New Ways to Control How Cells Change
Multiscale tools and approaches for understanding and engineering cell-fate transitions
This project explores how to use biological systems to control cell behavior, especially for potential future treatments like fighting cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11146661 on NIH RePORTER |
What this research studies
This project uses advanced biological tools to understand how cells decide what they will become, like a skin cell or a muscle cell. Researchers want to learn how to guide these cell decisions, which is called cell-fate reprogramming. This knowledge could help us develop new ways to detect and fight diseases like cancer, where cells behave abnormally. By understanding how cancer genes take over normal cell processes, we hope to create new cell-based therapies.
Who could benefit from this research
Good fit: This foundational work does not directly involve patients, but future clinical applications could benefit individuals with conditions like cancer who might be candidates for advanced cell therapies.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this early-stage, foundational research.
Why it matters
Potential benefit: If successful, this work could lead to new cell-based therapies for diseases like cancer by allowing us to precisely control cell behavior.
How similar studies have performed: This project builds upon previous work to identify principles of cell-fate transitions, suggesting a foundation of existing knowledge in this emerging field.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Galloway, Kate Elizabeth — Massachusetts Institute of Technology
- Study coordinator: Galloway, Kate Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.